Cnd Life Sciences

Cnd Life Sciences company information, Employees & Contact Information

CND Life Sciences is dedicated to supporting the care of patients suffering from neurodegenerative diseases and other conditions. Operating a CLIA-certified and CAP-accredited laboratory in Scottsdale, AZ, CND launched the Syn-One Test® as the first commercially available test to detect, visualize, and quantify the presence of misfolded phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid in the confirmation of a synucleinopathy in patients with suspected Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF). Through analysis of three small in-office skin biopsies provided by a referring physician, CND offers a convenient, accurate, minimally invasive alternative to aid in the diagnosis of neurodegenerative diseases. The company has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field.

Company Details

Employees
107
Founded
-
Address
9165 E Del Camino Dr, Scottsdale,arizona 85258,united States
Phone
480-569-2900
Industry
Medical And Diagnostic Laboratories
NAICS
Medical and Diagnostic Laboratories
Medical Laboratories
Diagnostic Imaging Centers
HQ
Scottsdale, Arizona
Looking for a particular Cnd Life Sciences employee's phone or email?

Cnd Life Sciences Questions

News

CND Life Sciences is Granted FDA Breakthrough Device Designation for Its Skin Biopsy-Based Syn-One Test® - PR Newswire

CND Life Sciences is Granted FDA Breakthrough Device Designation for Its Skin Biopsy-Based Syn-One Test® PR Newswire

CND Life Sciences Announces NIH Grant to Study the Risk of Parkinson's Disease in Patients with Essential Tremor - Lelezard

CND Life Sciences Announces NIH Grant to Study the Risk of Parkinson's Disease in Patients with Essential Tremor Lelezard

CND Life Sciences Closes $13.5M Series A Equity Round to Continue Growth and Innovation in Neurodiagnostics - PR Newswire

CND Life Sciences Closes $13.5M Series A Equity Round to Continue Growth and Innovation in Neurodiagnostics PR Newswire

Diagnosing Synucleinopathies with Skin Biopsies - the-scientist.com

Diagnosing Synucleinopathies with Skin Biopsies the-scientist.com

CND Life Sciences to Present Updates from Three Clinical Trials Involving Their Skin Biopsy Diagnostic Tool for Dementia and Other Related Disorders at the American Academy of Neurology 2025 Annual Meeting - PR Newswire

CND Life Sciences to Present Updates from Three Clinical Trials Involving Their Skin Biopsy Diagnostic Tool for Dementia and Other Related Disorders at the American Academy of Neurology 2025 Annual Meeting PR Newswire

VILAS Ventures Invests in $13.5M Series A3 Round for CND Life Sciences to Advance Neurodegenerative Diagnostics - Yahoo Finance

VILAS Ventures Invests in $13.5M Series A3 Round for CND Life Sciences to Advance Neurodegenerative Diagnostics Yahoo Finance

Skin biopsies may reveal new insights about long COVID - yourvalley.net

Skin biopsies may reveal new insights about long COVID yourvalley.net

Skin Test Detects Neurodegeneration Risk in 75% of iRBD Cases, With Todd Levine, MD - HCPLive

Skin Test Detects Neurodegeneration Risk in 75% of iRBD Cases, With Todd Levine, MD HCPLive

Scottsdale's CND Life Sciences secures $13.5M to expand disease diagnostics - The Business Journals

Scottsdale's CND Life Sciences secures $13.5M to expand disease diagnostics The Business Journals

CND Life Sciences to Highlight Momentum of Skin Biopsy Diagnostic Tool for Parkinson’s Disease and Related Disorders at the American Academy of Neurology 2024 Annual Meeting - Business Wire

CND Life Sciences to Highlight Momentum of Skin Biopsy Diagnostic Tool for Parkinson’s Disease and Related Disorders at the American Academy of Neurology 2024 Annual Meeting Business Wire

CND Life Sciences: $13.5 Million Series A Closed For Neurodiagnostics Innovations - Pulse 2.0

CND Life Sciences: $13.5 Million Series A Closed For Neurodiagnostics Innovations Pulse 2.0

Scottsdale doctor helps create skin test to help detect diseases like Parkinson’s or dementia - AZ Family

Scottsdale doctor helps create skin test to help detect diseases like Parkinson’s or dementia AZ Family

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases - PR Newswire

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases PR Newswire

Medical diagnostics company CND Life Sciences expands to new Scottsdale HQ - The Business Journals

Medical diagnostics company CND Life Sciences expands to new Scottsdale HQ The Business Journals

CND Life Sciences Receives Grant from The Michael J. Fox Foundation to Study Quantification of Cutaneous Phosphorylated Alpha-Synuclein (P-SYN) in People with Parkinson's Disease - PR Newswire

CND Life Sciences Receives Grant from The Michael J. Fox Foundation to Study Quantification of Cutaneous Phosphorylated Alpha-Synuclein (P-SYN) in People with Parkinson's Disease PR Newswire

CND Life Sciences Expands Leadership Team with Four Key Executive Appointments - PR Newswire

CND Life Sciences Expands Leadership Team with Four Key Executive Appointments PR Newswire

CND Life Sciences' Syn-One Test® Detects Alpha-Synuclein in Skin Biopsies of Patients with REM Sleep Behavior Disorder - PR Newswire

CND Life Sciences' Syn-One Test® Detects Alpha-Synuclein in Skin Biopsies of Patients with REM Sleep Behavior Disorder PR Newswire

CND Life Sciences Enters into Licensing and Collaboration Agreement to Advance Diagnostic Technology for Neurodegenerative Diseases - PR Newswire

CND Life Sciences Enters into Licensing and Collaboration Agreement to Advance Diagnostic Technology for Neurodegenerative Diseases PR Newswire

CND Life Sciences Awarded NIH SBIR Grant to Study Novel Skin Biopsy Test for Dementias - PR Newswire

CND Life Sciences Awarded NIH SBIR Grant to Study Novel Skin Biopsy Test for Dementias PR Newswire

Top Cnd Life Sciences Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant